Expression of RPL35 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

RPL35 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 2354.04

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

2321.3

Number of samples

141

Samples

Sample	Description	pTPM
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	7068.8
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	6248.6
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	6227.2
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	6017.3
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	5535.0
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	5419.5
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	4233.4
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	4134.2
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	4075.1
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	3980.0
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	3867.5
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	3774.2
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	3769.3
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	3725.8
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	3589.5
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	3573.0
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	3516.1
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	3464.3
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	3312.3
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	3293.5
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	3286.0
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	3249.5
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	3184.1
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	3125.2
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	3123.7
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	3059.3
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	2906.1
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	2848.8
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	2848.8
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	2845.4
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	2842.8
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	2807.8
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	2772.3
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	2751.8
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	2705.6
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	2691.6
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	2665.3
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	2651.4
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	2626.2
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	2625.3
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	2581.5
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	2571.7
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	2513.6
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	2494.5
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	2482.3
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	2450.1
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	2444.3
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	2416.7
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	2398.5
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	2393.7
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	2382.7
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	2364.9
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	2343.2
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	2336.0
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	2329.4
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	2301.2
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	2290.0
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	2282.3
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	2269.2
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	2263.3
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	2257.6
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	2234.1
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	2193.6
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	2191.8
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	2161.2
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	2140.7
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	2137.7
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	2096.6
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	2093.7
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	2039.0
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	2016.9
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	2015.1
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	2005.8
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	1973.9
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	1969.5
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	1966.6
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	1961.2
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	1955.2
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	1943.9
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	1926.8
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	1915.7
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	1914.1
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	1897.6
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	1877.7
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	1766.3
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	1763.6
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	1741.8
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	1740.3
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	1730.3
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	1713.8
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	1709.4
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	1702.8
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	1697.2
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	1696.4
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	1682.3
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	1670.0
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	1668.3
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	1663.4
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	1661.2
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	1659.2
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	1657.5
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	1654.4
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	1645.7
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	1624.7
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	1614.3
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	1598.2
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	1593.5
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	1591.7
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	1584.6
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	1573.9
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	1573.6
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	1572.5
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	1564.5
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	1544.7
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	1527.2
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	1524.3
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	1504.5
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	1503.2
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	1501.9
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	1460.1
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	1437.7
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	1437.1
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	1405.0
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	1404.5
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	1396.2
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	1361.5
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	1304.1
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	1264.4
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	1263.2
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	1262.0
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	1213.3
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	1196.9
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	1181.2
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	1179.4
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	1154.2
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	1063.7
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	1024.9
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	1004.0
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	982.1
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	930.5
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	924.4
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

RPL35 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 456.5

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

382.1

Number of samples

Samples

Sample	Description	pTPM
AK185	N, NA, stage:NA, alive, 330 days	802.9
AK074	N, NA, stage:NA, alive, 300 days	677.1
AK139	N, NA, stage:NA, dead, 270 days	665.5
AK236	N, NA, stage:NA, dead, 360 days	656.7
AK098	N, NA, stage:NA, dead, 660 days	644.7
AK165	N, NA, stage:NA, alive, 360 days	630.0
AK049	N, NA, stage:NA, dead, 180 days	618.7
AK043	N, NA, stage:NA, alive, 660 days	587.6
AK142	N, NA, stage:NA, alive, 90 days	574.0
AK199	N, NA, stage:NA, alive, 1860 days	573.7
AK183	N, NA, stage:NA, alive, 360 days	570.3
AK068	N, NA, stage:NA, alive, 360 days	568.8
AK051	N, NA, stage:NA, dead, 360 days	533.8
AK055	N, NA, stage:NA, dead, 240 days	520.5
AK153	N, NA, stage:NA, dead, 240 days	504.3
AK195	N, NA, stage:NA, dead, 390 days	503.8
AK124	N, NA, stage:NA, alive, 1920 days	500.4
AK053	N, NA, stage:NA, dead, 300 days	498.1
AK188	N, NA, stage:NA, alive, 420 days	460.8
AK066	N, NA, stage:NA, alive, 960 days	459.6
AK002	N, NA, stage:NA, dead, 570 days	453.4
AK178	N, NA, stage:NA, dead, 240 days	443.9
AK231	N, NA, stage:NA, dead, 240 days	440.8
AK133	N, NA, stage:NA, dead, 360 days	437.5
AK071	N, NA, stage:NA, dead, 540 days	405.0
AK213	N, NA, stage:NA, alive, 2010 days	399.8
AK088	N, NA, stage:NA, dead, 360 days	374.9
AK216	N, NA, stage:NA, dead, 360 days	371.5
AK158	N, NA, stage:NA, dead, 360 days	365.5
AK134	N, NA, stage:NA, dead, 360 days	356.6
AK167	N, NA, stage:NA, dead, 180 days	356.4
AK076	N, NA, stage:NA, alive, 660 days	354.2
AK035	N, NA, stage:NA, dead, 210 days	353.1
AK072	N, NA, stage:NA, dead, 150 days	327.4
AK089	N, NA, stage:NA, dead, 330 days	321.4
AK091	N, NA, stage:NA, dead, 210 days	301.2
AK173	N, NA, stage:NA, dead, 180 days	286.7
AK015	N, NA, stage:NA, alive, 720 days	285.6
AK149	N, NA, stage:NA, dead, 420 days	285.0
AK218	N, NA, stage:NA, dead, 180 days	281.4
AK100	N, NA, stage:NA, alive, 960 days	274.4
AK205	N, NA, stage:NA, dead, 120 days	260.0
AK227	N, NA, stage:NA, alive, 300 days	253.9
AK123	N, NA, stage:NA, dead, 180 days	253.3
AK030	N, NA, stage:NA, dead, 120 days	252.5
AK079	N, NA, stage:NA, dead, 210 days	240.4
AK003	N, NA, stage:NA, dead, 600 days	215.1
AK156	N, NA, stage:NA, dead, 330 days	194.3
AK117	N, NA, stage:NA, dead, 210 days	193.1
AK081	N, NA, stage:NA, dead, 180 days	178.0
AK005	N, NA, stage:NA, dead, 240 days	170.5
AK226	N, NA, stage:NA, dead, 360 days	162.8
AK099	N, NA, stage:NA, dead, 420 days	154.9
AK006	N, NA, stage:NA, dead, 360 days	147.8
AK041	N, NA, stage:NA, alive, 810 days	137.5
AK102	N, NA, stage:NA, alive, 1740 days	122.9
AK085	N, NA, stage:NA, alive, 660 days	113.4
AK103	N, NA, stage:NA, alive, 1320 days	89.4
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0182580003	Tumor	1.4
CPT0125510003	Tumor	1.2
CPT0204400003	Normal	1.0
CPT0162100003	Tumor	0.9
CPT0228220003	Tumor	0.8
CPT0217000004	Tumor	0.7
CPT0224540004	Tumor	0.7
CPT0127480003	Tumor	0.7
CPT0093550003	Tumor	0.6
CPT0190360004	Tumor	0.5
CPT0206560003	Tumor	0.5
CPT0189750004	Tumor	0.5
CPT0218690004	Tumor	0.4
CPT0208980003	Tumor	0.4
CPT0224390004	Tumor	0.4
CPT0167640003	Tumor	0.4
CPT0218830004	Tumor	0.4
CPT0217100003	Tumor	0.4
CPT0162020003	Tumor	0.4
CPT0225730003	Tumor	0.4
CPT0224600003	Tumor	0.3
CPT0093510003	Tumor	0.3
CPT0205570003	Tumor	0.3
CPT0206000004	Tumor	0.3
CPT0217710008	Tumor	0.3
CPT0168080003	Tumor	0.3
CPT0225760003	Tumor	0.3
CPT0093450003	Tumor	0.3
CPT0171580008	Tumor	0.2
CPT0206230003	Tumor	0.1
CPT0221180003	Tumor	0.1
CPT0205670004	Tumor	0.1
CPT0089150003	Tumor	0.1
CPT0079790003	Tumor	0.1
CPT0217430008	Tumor	0.0
CPT0216920008	Tumor	0.0
CPT0093360003	Tumor	0.0
CPT0127420003	Tumor	0.0
CPT0205450004	Tumor	0.0
CPT0123530003	Tumor	0.0
CPT0078580003	Tumor	-0.1
CPT0125570003	Tumor	-0.1
CPT0205780003	Tumor	-0.1
CPT0168830003	Tumor	-0.1
CPT0218330004	Tumor	-0.1
CPT0217880003	Tumor	-0.1
CPT0168720003	Tumor	-0.2
CPT0167530003	Tumor	-0.2
CPT0168270003	Tumor	-0.2
CPT0093590003	Tumor	-0.2
CPT0206880003	Tumor	-0.2
CPT0204380003	Normal	-0.2
CPT0206330003	Tumor	-0.3
CPT0064650003	Tumor	-0.3
CPT0168590003	Tumor	-0.3
CPT0175060003	Tumor	-0.3
CPT0092440003	Tumor	-0.3
CPT0087680003	Tumor	-0.3
CPT0087730003	Tumor	-0.3
CPT0087950003	Tumor	-0.3
CPT0182500003	Tumor	-0.4
CPT0167860004	Tumor	-0.4
CPT0071100003	Tumor	-0.4
CPT0002410011	Tumor	-0.4
CPT0104220003	Tumor	-0.4
CPT0209440003	Tumor	-0.5
CPT0189650004	Tumor	-0.5
CPT0199770003	Tumor	-0.5
CPT0218770003	Tumor	-0.5
CPT0087570003	Tumor	-0.5
CPT0206670004	Tumor	-0.5
CPT0161730003	Tumor	-0.6
CPT0218890004	Tumor	-0.6
CPT0064890003	Tumor	-0.6
CPT0182550003	Tumor	-0.6
CPT0186100003	Tumor	-0.6
CPT0217190003	Tumor	-0.6
CPT0205890003	Tumor	-0.6
CPT0206450003	Tumor	-0.6
CPT0196850003	Tumor	-0.6
CPT0219080004	Tumor	-0.7
CPT0201710003	Tumor	-0.7
CPT0206110003	Tumor	-0.7
CPT0217060003	Tumor	-0.7
CPT0167750004	Tumor	-0.8
CPT0167970003	Tumor	-0.8
CPT0204350003	Normal	-0.8
CPT0189570004	Tumor	-0.8
CPT0207090003	Tumor	-0.8
CPT0204340003	Normal	-0.9
CPT0168480003	Tumor	-0.9
CPT0206780003	Tumor	-0.9
CPT0207030003	Tumor	-0.9
CPT0204420003	Normal	-0.9
CPT0189460003	Tumor	-0.9
CPT0168380003	Tumor	-0.9
CPT0204390003	Normal	-0.9
CPT0204410003	Normal	-0.9
CPT0224330003	Tumor	-1.0
CPT0189850004	Tumor	-1.0
CPT0162140003	Tumor	-1.0
CPT0218670003	Tumor	-1.0
CPT0104330003	Tumor	-1.0
CPT0189250003	Tumor	-1.1
CPT0204330003	Normal	-1.1
CPT0125220003	Tumor	-1.1
CPT0204360003	Normal	-1.2
CPT0218960004	Tumor	-1.2
CPT0204370003	Normal	-1.2
CPT0190240004	Tumor	-1.5
Show allShow less

GLIOMA - Protein expressionⁱ A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Antibody stainingⁱ Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.	Antibody HPA006047
Staining
High
Medium
Low
Not detected
Intensity
Strong
Moderate
Weak
Negative
Quantity
>75%
75%-25%
<25%
None
Location
Nuclear
Cytoplasmic/membranous
Cytoplasmic/membranous,nuclear
None
Glioma, malignant, Low grade
Glioma, malignant, High grade